219 related articles for article (PubMed ID: 32144319)
21. Anthocyanin Rich-Black Soybean Testa Improved Visceral Fat and Plasma Lipid Profiles in Overweight/Obese Korean Adults: A Randomized Controlled Trial.
Lee M; Sorn SR; Park Y; Park HK
J Med Food; 2016 Nov; 19(11):995-1003. PubMed ID: 27809637
[TBL] [Abstract][Full Text] [Related]
22. Text messaging (SMS) as a tool to facilitate weight loss and prevent metabolic deterioration in clinically healthy overweight and obese subjects: a randomised controlled trial.
Silina V; Tessma MK; Senkane S; Krievina G; Bahs G
Scand J Prim Health Care; 2017 Sep; 35(3):262-270. PubMed ID: 28812403
[TBL] [Abstract][Full Text] [Related]
23. [Influence of a combination of lactobacilli and bifidobacteria upon disease activity, stool pattern and nutritional status of ulcerative colitis patients].
Santana Porbén S
Nutr Hosp; 2010; 25(6):971-83. PubMed ID: 21519769
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
25. Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
Kim J; Yun JM; Kim MK; Kwon O; Cho B
J Med Food; 2018 May; 21(5):454-461. PubMed ID: 29688793
[TBL] [Abstract][Full Text] [Related]
26. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
[TBL] [Abstract][Full Text] [Related]
27. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.
Maki KC; Beiseigel JM; Jonnalagadda SS; Gugger CK; Reeves MS; Farmer MV; Kaden VN; Rains TM
J Am Diet Assoc; 2010 Feb; 110(2):205-14. PubMed ID: 20102847
[TBL] [Abstract][Full Text] [Related]
28. Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet.
Zarrati M; Salehi E; Nourijelyani K; Mofid V; Zadeh MJ; Najafi F; Ghaflati Z; Bidad K; Chamari M; Karimi M; Shidfar F
J Am Coll Nutr; 2014; 33(6):417-25. PubMed ID: 25079040
[TBL] [Abstract][Full Text] [Related]
29. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients--a randomized double-blind placebo-controlled pilot study.
Sharafedtinov KK; Plotnikova OA; Alexeeva RI; Sentsova TB; Songisepp E; Stsepetova J; Smidt I; Mikelsaar M
Nutr J; 2013 Oct; 12():138. PubMed ID: 24120179
[TBL] [Abstract][Full Text] [Related]
30. Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects.
Uebelhack R; Bongartz U; Seibt S; Bothe G; Chong PW; De Costa P; Wszelaki N
J Obes; 2019; 2019():3412952. PubMed ID: 30863632
[TBL] [Abstract][Full Text] [Related]
31. Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial.
Michalickova D; Minic R; Dikic N; Andjelkovic M; Kostic-Vucicevic M; Stojmenovic T; Nikolic I; Djordjevic B
Appl Physiol Nutr Metab; 2016 Jul; 41(7):782-9. PubMed ID: 27363733
[TBL] [Abstract][Full Text] [Related]
32. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
[TBL] [Abstract][Full Text] [Related]
33. Flaxseed Mucilage (IQP-LU-104) Reduces Body Weight in Overweight and Moderately Obese Individuals in a 12-week, Three-Arm, Double-Blind, Randomized, and Placebo-Controlled Clinical Study.
Bongartz U; Hochmann U; Grube B; Uebelhack R; Alt F; Erlenbeck C; Peng LV; Chong PW; De Costa P
Obes Facts; 2022; 15(3):395-404. PubMed ID: 35130547
[TBL] [Abstract][Full Text] [Related]
34. Clinical and psychological responses to synbiotic supplementation in obese or overweight adults: A randomized clinical trial.
Hadi A; Sepandi M; Marx W; Moradi S; Parastouei K
Complement Ther Med; 2019 Dec; 47():102216. PubMed ID: 31780038
[TBL] [Abstract][Full Text] [Related]
35. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
36. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
[TBL] [Abstract][Full Text] [Related]
37. Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study.
Garaiova I; Muchová J; Nagyová Z; Wang D; Li JV; Országhová Z; Michael DR; Plummer SF; Ďuračková Z
Eur J Clin Nutr; 2015 Mar; 69(3):373-9. PubMed ID: 25205320
[TBL] [Abstract][Full Text] [Related]
38. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults.
Hibberd AA; Yde CC; Ziegler ML; Honoré AH; Saarinen MT; Lahtinen S; Stahl B; Jensen HM; Stenman LK
Benef Microbes; 2019 Mar; 10(2):121-135. PubMed ID: 30525950
[TBL] [Abstract][Full Text] [Related]
39. Exenatide in obese or overweight patients without diabetes: A systematic review and meta-analyses of randomized controlled trials.
Su N; Li Y; Xu T; Li L; Kwong JS; Du H; Ren K; Li Q; Li J; Sun X; Li S; Tian H
Int J Cardiol; 2016 Sep; 219():293-300. PubMed ID: 27343423
[TBL] [Abstract][Full Text] [Related]
40. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
Pi-Sunyer FX; Aronne LJ; Heshmati HM; Devin J; Rosenstock J;
JAMA; 2006 Feb; 295(7):761-75. PubMed ID: 16478899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
